Currently, patients can use only those drugs which are approved by the drug regulator after it has passed clinical trials and found safe and efficacious, a process that takes several years. However, a new policy in the works will allow them to access pre-approval drugs in cases of serious and life-threatening diseases on compassionate grounds, without clearing clinical trials.from Moneycontrol Business News https://ift.tt/2KVOaWm
No comments:
Post a Comment